Back to search

Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive induction chemotherapy regimen for patients with high‐risk multiple myeloma

Data up to Jan 2025

Published1997
Citations19
References0

Total Citations Per Year

Abstract

References (0)

No references found

Cited By (0)

Loading...
Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC‐IE): a novel, intensive… (1997) – British Journal of Haematology | Metascience Observatory Explorer